{
  "success": true,
  "pagesUsed": [
    2,
    4,
    10,
    12,
    15,
    17,
    20,
    25,
    27,
    29,
    32,
    37,
    39,
    40,
    41,
    42,
    57
  ],
  "modelUsed": "gemini-2.5-pro",
  "confidence": 1.0,
  "scheduling": {
    "timings": [
      {
        "id": "timing_1",
        "name": "End of Study Visit Window",
        "type": {
          "id": "0ddfbef5-2f68-42e0-acd7-3a8c1cf560be",
          "code": "C71148",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Fixed Reference",
          "instanceType": "Code"
        },
        "value": "P54D",
        "valueLabel": "Day 54",
        "relativeToFrom": {
          "id": "542dc31b-80bb-4e70-bf0b-97c103dddda4",
          "code": "C71155",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "First Dose",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "7ab8280c-696f-4af1-a4a7-e4547d7636e2",
        "instanceType": "Timing",
        "windowLower": "-P2D",
        "windowUpper": "P2D"
      },
      {
        "id": "timing_2",
        "name": "Zinc Washout Period",
        "type": {
          "id": "dba09682-0ba3-474b-95c2-e1499c223683",
          "code": "C71149",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Before",
          "instanceType": "Code"
        },
        "value": "P21D",
        "valueLabel": "Day 21",
        "relativeToFrom": {
          "id": "b0722b98-52ce-4864-9e5f-1f1d740fac8b",
          "code": "C71155",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "First Dose",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "8f70b253-dafe-476d-b6db-618030733b45",
        "instanceType": "Timing",
        "windowLower": "P0D",
        "windowUpper": "P0D"
      },
      {
        "id": "timing_3",
        "name": "Chelator Therapy Washout",
        "type": {
          "id": "00f2d35c-c4d5-4fc1-b019-6f2a259014b2",
          "code": "C71149",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Before",
          "instanceType": "Code"
        },
        "value": "P4D",
        "valueLabel": "Day 4",
        "relativeToFrom": {
          "id": "a1d86fa6-57e5-41e7-8ddf-a62e531f2323",
          "code": "C71155",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "First Dose",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "5b62e119-256a-426a-ad79-5f83d40562cc",
        "instanceType": "Timing",
        "windowLower": "P0D",
        "windowUpper": "P0D"
      },
      {
        "id": "timing_4",
        "name": "Experimental Therapy Washout",
        "type": {
          "id": "a20f616a-8163-4b82-9dfe-b868f2cb74eb",
          "code": "C71149",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Before",
          "instanceType": "Code"
        },
        "value": "P90D",
        "valueLabel": "Day 90",
        "relativeToFrom": {
          "id": "d2533e94-5cae-489e-bead-a857c588c0c9",
          "code": "C71158",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Screening",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "81f1207d-7d5c-4595-b543-b9039fc5c8f6",
        "instanceType": "Timing",
        "windowLower": "P0D",
        "windowUpper": "P0D"
      },
      {
        "id": "timing_5",
        "name": "Tetrathiomolybdate Washout",
        "type": {
          "id": "c281e1f9-bd2c-4b5a-bb30-41e10cbccf02",
          "code": "C71149",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Before",
          "instanceType": "Code"
        },
        "value": "P1D",
        "valueLabel": "1 years",
        "relativeToFrom": {
          "id": "1f9c3395-0003-4d52-8acb-f0c3e5c0b299",
          "code": "C71155",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "First Dose",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "cd3f01f5-9958-4ae5-9ef9-27394065d014",
        "instanceType": "Timing",
        "windowLower": "P0D",
        "windowUpper": "P0D"
      },
      {
        "id": "timing_6",
        "name": "Prescription Medication Washout",
        "type": {
          "id": "d38073a1-b871-45aa-9467-8058d3065606",
          "code": "C71149",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Before",
          "instanceType": "Code"
        },
        "value": "P14D",
        "valueLabel": "Day 14",
        "relativeToFrom": {
          "id": "019c95de-4f88-46ea-b8cd-151106754d82",
          "code": "C71153",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Study Start",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "66b1a539-c4dd-4f55-bc95-912aa6aba776",
        "instanceType": "Timing",
        "windowLower": "P0D",
        "windowUpper": "P0D"
      },
      {
        "id": "timing_7",
        "name": "Non-Prescription Medication Washout",
        "type": {
          "id": "5ac43dd4-f98f-4a63-b3d4-deb17da3628f",
          "code": "C71149",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Before",
          "instanceType": "Code"
        },
        "value": "P7D",
        "valueLabel": "Day 7",
        "relativeToFrom": {
          "id": "04b0cab6-0674-46da-88f9-b96f4a724014",
          "code": "C71153",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Study Start",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "34155dc7-0feb-4539-9618-c6d654555fd9",
        "instanceType": "Timing",
        "windowLower": "P0D",
        "windowUpper": "P0D"
      },
      {
        "id": "timing_8",
        "name": "Alcohol Abstinence",
        "type": {
          "id": "c6b5da7a-43d9-4aa6-8a80-60893b8e7fe4",
          "code": "C71149",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Before",
          "instanceType": "Code"
        },
        "value": "PT48H",
        "valueLabel": "48 hours",
        "relativeToFrom": {
          "id": "3ffc5121-f13a-4d6c-bdc7-3bf410e77cb9",
          "code": "C71155",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "First Dose",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "c7e44102-6133-4dbc-b3bd-7c4ef44dadc9",
        "instanceType": "Timing",
        "windowLower": "P0D",
        "windowUpper": "P0D"
      },
      {
        "id": "timing_9",
        "name": "Pregnancy Test Interval",
        "type": {
          "id": "1a2fc12f-ae9e-45e4-8e6e-199cd9bc21ad",
          "code": "C71148",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Fixed Reference",
          "instanceType": "Code"
        },
        "value": "P4W",
        "valueLabel": "4 weeks",
        "relativeToFrom": {
          "id": "99549b0a-7330-4541-a504-9937374d616c",
          "code": "C71157",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Previous Visit",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "be8d444f-c28f-4f25-809b-d90bd9973e6d",
        "instanceType": "Timing",
        "windowLower": "P0D",
        "windowUpper": "P0D"
      },
      {
        "id": "timing_10",
        "name": "Outpatient Dosing Window",
        "type": {
          "id": "f09007d2-53f1-4d38-a9c9-c26da8f3582b",
          "code": "C71148",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Fixed Reference",
          "instanceType": "Code"
        },
        "value": "PT0H",
        "valueLabel": "Outpatient Dosing Window",
        "relativeToFrom": {
          "id": "c78f059a-aa93-49c8-8911-0f77f52a6c15",
          "code": "C71153",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Study Start",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "86a6969a-8b63-4b5c-ad1c-f6e2fa5c5c4e",
        "instanceType": "Timing",
        "windowLower": "-PT1H",
        "windowUpper": "PT1H"
      },
      {
        "id": "timing_11",
        "name": "15mg Dose Period",
        "type": {
          "id": "df07cac7-4e63-4a37-8234-7600fb10dff5",
          "code": "C71152",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Between",
          "instanceType": "Code"
        },
        "value": "P1D",
        "valueLabel": "Day 1",
        "relativeToFrom": {
          "id": "7e02faf5-5575-4069-b30e-334789781c8d",
          "code": "C71155",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "First Dose",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "9045b1ad-a828-47dd-aeca-820568b75a25",
        "instanceType": "Timing",
        "windowLower": "P0D",
        "windowUpper": "P0D"
      },
      {
        "id": "timing_12",
        "name": "30mg Dose Period",
        "type": {
          "id": "7e2a1a33-6b40-44f6-a3c5-a7d281bf53af",
          "code": "C71152",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Between",
          "instanceType": "Code"
        },
        "value": "P29D",
        "valueLabel": "Day 29",
        "relativeToFrom": {
          "id": "2eb17496-428b-4ee4-94e4-fd9499966ad0",
          "code": "C71155",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "First Dose",
          "instanceType": "Code"
        },
        "relativeFromScheduledInstanceId": "c8b74128-9272-427b-b366-079cfaad4712",
        "instanceType": "Timing",
        "windowLower": "P0D",
        "windowUpper": "P0D"
      }
    ],
    "conditions": [
      {
        "id": "cond_1",
        "name": "Moderate Transaminase Elevation",
        "instanceType": "Condition",
        "description": "Criteria for dose reduction due to moderate liver enzyme elevation.",
        "text": "ALT or AST > 3 × ULN and ≤ 5 × ULN"
      },
      {
        "id": "cond_2",
        "name": "High Transaminase Elevation",
        "instanceType": "Condition",
        "description": "Criteria for dose interruption due to high liver enzyme elevation.",
        "text": "ALT or AST > 5 × ULN"
      },
      {
        "id": "cond_3",
        "name": "Low Hemoglobin",
        "instanceType": "Condition",
        "description": "Criteria for dose reduction due to low hemoglobin.",
        "text": "Hemoglobin < 10 g/dL"
      },
      {
        "id": "cond_4",
        "name": "Low Platelets",
        "instanceType": "Condition",
        "description": "Criteria for dose reduction due to low platelet count.",
        "text": "Platelets < 100,000/mm3"
      },
      {
        "id": "cond_5",
        "name": "Low Neutrophils",
        "instanceType": "Condition",
        "description": "Criteria for dose reduction due to low neutrophil count.",
        "text": "Neutrophils > 30% decrease from baseline and below reference range at baseline"
      },
      {
        "id": "cond_6",
        "name": "Potential Liver Injury",
        "instanceType": "Condition",
        "description": "Criteria for dose interruption due to signs of potential liver injury.",
        "text": "Bilirubin > 2 × ULN accompanied by ALT > 3 × ULN"
      },
      {
        "id": "cond_7",
        "name": "Neurologic Worsening",
        "instanceType": "Condition",
        "description": "Criteria for evaluating dose modification due to neurologic worsening.",
        "text": "Evidence of neurologic worsening by AEs or by neurologic physical exam assessment"
      },
      {
        "id": "cond_8",
        "name": "Psychiatric Worsening",
        "instanceType": "Condition",
        "description": "Criteria for evaluating dose modification due to psychiatric worsening.",
        "text": "Evidence of clinically significant acute psychiatric worsening which may include but not limited to suicidality, acute depression, or psychosis."
      },
      {
        "id": "cond_9",
        "name": "Outpatient Period Extension",
        "instanceType": "Condition",
        "description": "Adaptive design feature allowing for extension of the outpatient period.",
        "text": "The Outpatient Period during Treatment Period 1 may be extended up to an additional 14 days with Investigator approval."
      },
      {
        "id": "cond_10",
        "name": "SRC Safety Review for Titration",
        "instanceType": "Condition",
        "description": "Safety review required before dose titration.",
        "text": "Before titration to 30 mg/day, the Safety Review Committee (SRC) will review available safety data through Day 23 for each participant."
      }
    ],
    "conditionAssignments": [],
    "transitionRules": [
      {
        "id": "trans_1",
        "name": "Dose Titration to 30mg",
        "instanceType": "TransitionRule",
        "transitionType": "Dose Modification",
        "fromElementId": "dose_15mg",
        "toElementId": "dose_30mg",
        "text": "Participants will be administered ALXN1840 at 15 mg/day for a treatment period of approximately 28 days followed by titration up to 30 mg/day on Day 29."
      },
      {
        "id": "trans_2",
        "name": "Dose Reduction for Moderate Transaminase Elevation",
        "instanceType": "TransitionRule",
        "transitionType": "Dose Modification",
        "text": "If ALT or AST > 3x ULN and <= 5x ULN, reduce dose to previous dose level or 15 mg QOD if on 15 mg QD."
      },
      {
        "id": "trans_3",
        "name": "Dose Interruption for High Transaminase Elevation",
        "instanceType": "TransitionRule",
        "transitionType": "Dose Modification",
        "text": "If ALT or AST > 5x ULN, temporarily interrupt dosing."
      },
      {
        "id": "trans_4",
        "name": "Dose Reduction for Low Hemoglobin or Platelets",
        "instanceType": "TransitionRule",
        "transitionType": "Dose Modification",
        "text": "If Hemoglobin < 10 g/dL or Platelets < 100,000/mm3, reduce dose to previous dose level or 15 mg QOD if on 15 mg QD."
      },
      {
        "id": "trans_5",
        "name": "Dose Interruption for Potential Liver Injury",
        "instanceType": "TransitionRule",
        "transitionType": "Dose Modification",
        "text": "If Bilirubin > 2x ULN accompanied by ALT > 3x ULN, temporarily interrupt dosing."
      },
      {
        "id": "trans_6",
        "name": "Dose Modification Evaluation for Neurologic Worsening",
        "instanceType": "TransitionRule",
        "transitionType": "Dose Modification",
        "text": "Investigator and Alexion Medical Monitor will evaluate the need for dose modification (interruption, increase or decrease) based on neurologic worsening."
      },
      {
        "id": "trans_7",
        "name": "Intervention Discontinuation for Hypersensitivity",
        "instanceType": "TransitionRule",
        "transitionType": "Discontinuation",
        "text": "Participants must be considered for discontinuation from study intervention for a serious hypersensitivity reaction."
      },
      {
        "id": "trans_8",
        "name": "Intervention Discontinuation for Infection",
        "instanceType": "TransitionRule",
        "transitionType": "Discontinuation",
        "text": "Participants must be considered for discontinuation from study intervention for a severe uncontrolled infection."
      },
      {
        "id": "trans_9",
        "name": "Intervention Discontinuation for Disallowed Medication",
        "instanceType": "TransitionRule",
        "transitionType": "Discontinuation",
        "text": "Participants must be considered for discontinuation from study intervention for use of disallowed medication."
      },
      {
        "id": "trans_10",
        "name": "Intervention Discontinuation for Pregnancy",
        "instanceType": "TransitionRule",
        "transitionType": "Discontinuation",
        "text": "Participants must be considered for discontinuation from study intervention for pregnancy or planned pregnancy."
      }
    ],
    "scheduleTimelineExits": [
      {
        "id": "exit_1",
        "name": "Study Completion",
        "exitType": "Completion",
        "instanceType": "ScheduleTimelineExit",
        "description": "A participant is considered to have completed the study if he/she has completed all phases of the study including the last scheduled procedure shown in the Schedule of Activities (SoA)."
      },
      {
        "id": "exit_2",
        "name": "Participant Withdrawal",
        "exitType": "Early Termination",
        "instanceType": "ScheduleTimelineExit",
        "description": "A participant may withdraw from the study at any time at his/her own request."
      },
      {
        "id": "exit_3",
        "name": "Investigator Discretionary Withdrawal",
        "exitType": "Early Termination",
        "instanceType": "ScheduleTimelineExit",
        "description": "A participant may be withdrawn at any time at the discretion of the Investigator for safety, behavioral, compliance, or administrative reasons."
      },
      {
        "id": "exit_4",
        "name": "Lost to Follow-up",
        "exitType": "Early Termination",
        "instanceType": "ScheduleTimelineExit",
        "description": "A participant will be considered lost to follow-up if he or she repeatedly fails to return for scheduled visits and is unable to be contacted by the study site."
      },
      {
        "id": "exit_5",
        "name": "Sponsor Termination of Study",
        "exitType": "Early Termination",
        "instanceType": "ScheduleTimelineExit",
        "description": "Alexion reserves the right to close the study site or terminate the study at any time for any reason at the sole discretion of Alexion."
      },
      {
        "id": "exit_6",
        "name": "Site Closure for Non-Compliance",
        "exitType": "Early Termination",
        "instanceType": "ScheduleTimelineExit",
        "description": "Early closure of a study site due to failure of the Investigator to comply with the protocol, the requirements of the IRB/IEC or local health authorities, Alexion’s procedures, or GCP guidelines."
      },
      {
        "id": "exit_7",
        "name": "Site Closure for Inadequate Recruitment",
        "exitType": "Early Termination",
        "instanceType": "ScheduleTimelineExit",
        "description": "Early closure of a study site due to inadequate recruitment of participants by the Investigator."
      }
    ],
    "scheduledDecisionInstances": [
      {
        "id": "dec_1",
        "name": "Dose Titration Safety Review",
        "timepointId": "Day23",
        "instanceType": "ScheduledDecisionInstance",
        "description": "Decision point for the SRC to review safety data prior to the planned dose titration on Day 29.",
        "conditionIds": [
          "cond_10"
        ]
      },
      {
        "id": "dec_2",
        "name": "Outpatient Period Extension Decision",
        "timepointId": "Day9",
        "instanceType": "ScheduledDecisionInstance",
        "description": "Decision point for the Investigator to extend the outpatient period for up to 14 additional days.",
        "conditionIds": [
          "cond_9"
        ]
      },
      {
        "id": "dec_3",
        "name": "Ongoing Dose Modification Decision",
        "timepointId": "ongoing",
        "instanceType": "ScheduledDecisionInstance",
        "description": "Ongoing safety monitoring that can trigger dose modification or interruption based on specific laboratory or clinical findings.",
        "conditionIds": [
          "cond_1",
          "cond_2",
          "cond_3",
          "cond_4",
          "cond_5",
          "cond_6",
          "cond_7",
          "cond_8"
        ]
      }
    ],
    "summary": {
      "timingCount": 12,
      "conditionCount": 10,
      "transitionRuleCount": 10,
      "exitCount": 7
    }
  }
}